Showing results (211-220 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|October 28, 1999
Cost comparison of antibacterial therapies for serious infections. A New Zealand 3-hospital studyW G Scott, H M Scott, S Henderson, et al.Pharmacoeconomics|October 28, 1999
Choice of cost-effectiveness measure in the economic evaluation of cholesterol-modifying pharmacotherapy. An illustrative example focusing on the primary prevention of coronary heart disease in CanadaS Morris, E GodberPharmacoeconomics|October 28, 1999
Primary care purchasing. Are integrated primary care provider/purchasers the way forward?S PeckhamPharmacoeconomics|October 28, 1999
Simvastatin after orthotopic heart transplantation. Costs and consequencesK J Krobot, K Wenke, B ReichartPharmacoeconomics|October 28, 1999
Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depressionR I Griffiths, E M Sullivan, R G Frank, et al.Pharmacoeconomics|October 28, 1999
Direct costs of hip fractures in patients over 60 years of age in BelgiumJ Y Reginster, P Gillet, W Ben Sedrine, et al.Pharmacoeconomics|March 21, 2000
Economic evaluation of long-term management strategies for erosive oesophagitisR Goeree, B O'Brien, R Hunt, et al.Pharmacoeconomics|March 21, 2000
Health economics in the Canadian pharmaceutical industryL Assiff, M R Pollock, P Manzi, et al.Pharmacoeconomics|June 3, 1999
Pharmacoeconomic considerations in treating patients with acute leukaemiaV Jønsson, M M Hansen, P Ljungman, et al.Pharmacoeconomics|August 18, 2000
Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committeesA Anell, P SvarvarPageof 335